Metachromatic leukodystrophy (MLD)
Metachromatic leukodystrophy (MLD) is a rare, inherited metabolic disorder that affects the nervous system. It is caused by a deficiency of the enzyme arylsulfatase A (ASA), which is responsible for breaking down a fatty substance called sulfatides. The accumulation of sulfatides in the nervous system leads to damage to the myelin sheath, which is the protective covering of nerve cells. This damage disrupts the transmission of nerve signals, leading to a progressive decline in motor and cognitive function.
Symptoms of MLD
The symptoms of MLD vary depending on the age of onset. In the infantile form, which is the most common, symptoms typically appear between 6 and 18 months of age. These symptoms may include:
- Developmental delays
- Muscle weakness
- Difficulty swallowing
- Speech problems
- Seizures
- Vision problems
In the late infantile form, symptoms typically appear between 1 and 3 years of age. These symptoms may include:
- Progressive loss of motor and cognitive skills
- Seizures
- Vision problems
- Hearing loss
- Swallowing difficulties
In the juvenile form, symptoms typically appear between 4 and 10 years of age. These symptoms may include:
- Behavioral problems
- Learning disabilities
- Speech problems
- Motor problems
- Seizures
In the adult form, symptoms typically appear between 15 and 40 years of age. These symptoms may include:
- Cognitive decline
- Motor problems
- Speech problems
- Psychiatric problems
Diagnosis of MLD
MLD is diagnosed based on a combination of physical examination, family history, and laboratory tests. The laboratory tests may include:
- Blood test to measure the level of ASA
- Urine test to measure the level of sulfatides
- Genetic testing to identify mutations in the ASA gene
Treatment for MLD
There is no cure for MLD. However, there are treatments that can help to slow the progression of the disease and improve the quality of life for patients. These treatments may include:
- Enzyme replacement therapy
- Bone marrow transplant
- Gene therapy
- Palliative care
Prognosis for MLD
The prognosis for MLD varies depending on the age of onset and the severity of the disease. In the infantile form, most patients die before the age of 5. In the late infantile form, most patients die before the age of 10. In the juvenile form, most patients die before the age of 20. In the adult form, the life expectancy is variable.
Research on MLD
There is currently a great deal of research being conducted on MLD. This research is focused on developing new treatments and improving the quality of life for patients.
The AI has provided us with the news.
I’ve asked Google Gemini the following question, and here’s its response.
Please search for “โรค mld” which is rapidly rising on Google Trends TH and explain in detail. Answers should be in English.
79